梁齐，副主任医师，医学博士
毕业于山东医科大学临床医疗系，1992年至2001在山东省肿瘤医院内科工作，在原CSCO副主任委员宋恕平教授指导下从事肿瘤内科的临床和科研工作。1997年获医学硕士学位；1998年受聘肿瘤内科主治医师。2001年至2004年师从著名肿瘤内科专家石远凯教授，在中国医学科学院肿瘤医院从事肿瘤内科及造血干细胞移植的临床和基础研究工作，2004年获医学博士学位。2005年9月获副主任医师资格。
严格遵循恶性肿瘤综合治疗的原则，主要从事肺癌、结直肠癌、恶性淋巴瘤及乳腺癌的化疗和分子靶向治疗，研究化疗耐药患者的治疗方法及抗血管新生药物在肿瘤治疗中的应用。注重患者一般状况的改善、免疫功能的重建和患者生活质量的提高，注重晚期肿瘤患者姑息治疗的合理应用。
参加了三十多项国内Ⅰ、Ⅱ、Ⅲ临床科研和国际多中心临床协作科研工作。为主参加的基础科研工作，分获山东省医科院科技成果二、三等奖各一项，毕业论文获医科院肿瘤医院天衡杯优秀论文奖。核心期刊发表论文十余篇。参加了《肿瘤内科学研究进展》、《恶性肿瘤转移学》、《肿瘤内科学——新技术、新理论、新方法》和《淋巴瘤》的编著。
Liang is uneven, deputy chief physician, medicine Dr. graduates from the Shandong Medical college clinical medical service department, 1992 to 2001 in the Shandong Province tumour hospital internal medicine department work, Committee Member Professor Song Shuping under the instruction were engaged in the tumor internal medicine department in original Assistant Director CSCO clinical and the scientific effort. in 1997 obtained the medicine master's degree; in 1998 was hired tumor internal medicine department doctor in charge. from 2001 to 2004 the teacher from renowned tumor internal medicine department expert Professor Shi Yuankai, was engaged in the tumor internal medicine department and the hematopoietic stem cell transplant in the Chinese Academy of Medical Sciences Tumour hospital clinical and the basic research work, in 2004 obtained the medicine doctorate. in September, 2005 attains deputy chief physician the qualifications. follows the malignant tumor complex therapy strictly the principle, is mainly engaged in the lung cancer, the colon cancer, the malignant lymphoma and breast cancer's chemotherapy and the molecular target to the treatment, the research chemotherapy bears the medicine patient's method of treatment and the anti-blood vessel newborn medicine in tumor treatment application. Pays great attention the patient general condition the improvement, the immunologic function reconstruction and the patient quality of life enhancement, pays great attention the later period tumor patient to appease the treatment the reasonable application. participated in more than 30 item of homesⅠ,Ⅱ,ⅢClinical scientific research and international multi-central clinical cooperation scientific effort. Participates primarily the foundation scientific effort, receives respectively Shandong Province Medical Research Institute scientific and technical payoffs two, third prize each one item, the graduation thesis wins the Medical Research Institute Tumour hospital day graduated arm cup outstanding paper prize. The core journal publishes paper ten. Participated in "Tumor Internal medicine Research development", "Malignant tumor Shift Study", "Tumor Internal medicine - - New Technology, New Theory, New Method" and "Lymphoma" writing. |
男科 
妇科
